Porter Richard, Booth David, Gray Hamish, Frampton Chris
Department of Psychological Medicine, University of Otago, Christchurch, New Zealand.
J ECT. 2008 Sep;24(3):203-7. doi: 10.1097/YCT.0b013e3181662ca0.
Propofol is a widely used anesthetic agent for electroconvulsive therapy (ECT). However, there are concerns that its anticonvulsant effect may interfere with the efficacy of ECT. We aimed to investigate the effects on seizure activity of the addition of the opiate remifentanil to propofol anesthesia for ECT.
A retrospective analysis of 633 treatments in 73 patients was conducted. At each treatment, patients had received anesthesia with propofol alone or propofol plus remifentanil, depending on which anesthetist was providing anesthesia. Analysis of variance was performed to examine the effects of the anesthetic used, the electrode placement, the dose of electricity administered, and the stage in the course of treatment. Dependent variables were electroencephalogram seizure length and postictal suppression index (PSI).
Addition of remifentanil resulted in a small but significantly lower dose of propofol being used to induce unconsciousness. Addition of remifentanil affected seizure length, mainly related to an effect when placement was right unilateral (F = 5.70; P = 0.017). There was also a significantly increased PSI (F = 4.3; P = 0.039), which was not dependent on dose or on placement.
The data suggest that addition of remifentanil to propofol anesthesia significantly alters seizure indices. This may be secondary to a reduction in the amount of propofol required or to an independent effect of remifentanil. The increase in PSI in particular suggests that addition of remifentanil may improve clinical response. However, this can only be examined in a randomized controlled trial.
丙泊酚是一种广泛用于电休克治疗(ECT)的麻醉剂。然而,人们担心其抗惊厥作用可能会干扰ECT的疗效。我们旨在研究在丙泊酚麻醉中添加阿片类药物瑞芬太尼对ECT癫痫活动的影响。
对73例患者的633次治疗进行回顾性分析。每次治疗时,患者根据提供麻醉的麻醉师不同,接受单独丙泊酚麻醉或丙泊酚加瑞芬太尼麻醉。进行方差分析以检查所用麻醉剂、电极放置、给予的电量以及治疗过程阶段的影响。因变量为脑电图癫痫发作时长和发作后抑制指数(PSI)。
添加瑞芬太尼导致诱导昏迷所需的丙泊酚剂量略有降低但具有显著差异。添加瑞芬太尼影响癫痫发作时长,主要与右侧单侧放置时的效果有关(F = 5.70;P = 0.017)。PSI也显著增加(F = 4.3;P = 0.039),这与剂量或放置无关。
数据表明,在丙泊酚麻醉中添加瑞芬太尼会显著改变癫痫指标。这可能是由于所需丙泊酚量的减少或瑞芬太尼的独立作用所致。特别是PSI的增加表明添加瑞芬太尼可能会改善临床反应。然而,这只能在随机对照试验中进行检验。